A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

NCT02742623 · clinicaltrials.gov ↗

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis and Pulmonary Embolism

Interventions

DRUG: Rivaroxaban (Xarelto, BAY 59-7939)

Sponsor

Bayer

Collaborators

[object Object]